| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
1e-13 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
9e-11 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-10 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-09 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-09 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
4e-08 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
8e-08 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-07 |